ArticleDrug design, development and therapy2014
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
Hiroyuki Daikuhara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.